Skip to content

Clinical trials

Myeloproliferative Disorders trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Israel Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20111
20131
20141
20161
20181
20191
20203
20216

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed5
Terminated4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Celgene2
Novartis Pharmaceuticals2
Carmel Medical Center1
Cellphire Therapeutics, Inc.1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Geron Corporation1
Karyopharm Therapeutics Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders16
Primary Myelofibrosis8
Myelodysplastic Syndromes6
Leukemia, Myeloid, Acute3
Polycythemia Vera3
Anemia2
Bone Marrow Diseases2
Hematologic Diseases2
Leukemia, Myelomonocytic, Chronic2
Lymphoma, Non-Hodgkin2

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.